LINDA A CLAYTON, M.D.
Medical Practice at Huntington Ave, Boston, MA
License number
Massachusetts 76617
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
677 Huntington Ave, Boston, MA 02115
Phone
(617) 495-7777
Personal information
See more information about LINDA A CLAYTON at radaris.comName
Address
Phone
42 Bulfinch St, Lynn, MA 01904
4 Montvale Ave, Gloucester, MA 01930
8 Cross St, Wellesley, MA 02482
8 Clearview Dr, Milford, MA 01757
Organization information
See more information about LINDA A CLAYTON at bizstanding.comLinda Clayton MD
677 Huntington Ave, Boston, MA 02115
Industry:
Obgyn
Phone:
(617) 495-7777 (Phone)
Linda Ann Clayton
Linda A Clayton MD
1575 Tremont St #1401, Roxbury Crossing, MA 02120
Categories:
Gynecology & Obstetrics Physicians & Surgeons, Oncology Physicians & Surgeons
Phone:
(617) 732-1234 (Phone)
Professional information
Assistant Professor At Dana-Farber Cancer Institute
Position:
Assistant Professor at Dana-Farber Cancer Institute
Location:
Greater Boston Area
Industry:
Research
Work:
Dana-Farber Cancer Institute
-
Assistant Professor
Dr. Linda A Clayton, Roxbury Crossing MA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1575 Tremont St SUITE 1401, Roxbury Crossing 02120
(617) 232-2251 (Phone)
677 Huntington Ave, Boston 02115
(617) 495-7777 (Phone)
(617) 232-2251 (Phone)
677 Huntington Ave, Boston 02115
(617) 495-7777 (Phone)
Languages:
English
Education:
Medical School
Duke University
Graduated: 1975
Duke University Med School
Duke University
Graduated: 1975
Duke University Med School
Linda Ann Clayton, Boston MA
Specialties:
OB-GYN
Address:
677 Huntington Ave, Boston, MA 02115
1575 Tremont St, Roxbury Crossing, MA 02120
1575 Tremont St, Roxbury Crossing, MA 02120
Alteration Of Ability Of Soluble Cd4 Fragments To Bind Hiv
US Patent:
5109123, Apr 28, 1992
Filed:
Jul 11, 1988
Appl. No.:
7/217475
Inventors:
Ellis L. Reinherz - Lincoln MA
Linda K. Clayton - Jamaica Plain MA
Linda K. Clayton - Jamaica Plain MA
Assignee:
Dana Farber Cancer Institute - Boston MA
International Classification:
C07H 1512, C12N 1500
US Classification:
536 27
Abstract:
DNA encoding modified soluble human CD4 fragments whose ability to bind to the HIV gp120 envelope protein is different from the ability of soluble human CD4 fragments; modified soluble human CD4 fragments having altered gp120 binding ability, methods of making such fragments and methods of using such fragments.
Identification Of The Ikappabns Protein And Its Products
US Patent:
2005008, Apr 21, 2005
Filed:
Feb 20, 2004
Appl. No.:
10/783994
Inventors:
Ellis Reinherz - Lincoln MA, US
Linda Clayton - Jamaica Plain MA, US
Emma Fiorini - Cambridge MA, US
Pedro Reche - Boston MA, US
Ingo Schmitz - Kaarst, DE
Linda Clayton - Jamaica Plain MA, US
Emma Fiorini - Cambridge MA, US
Pedro Reche - Boston MA, US
Ingo Schmitz - Kaarst, DE
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
G01N033/574, C07H021/04, C12N009/64
US Classification:
435007230, 536023200, 435069100, 435226000, 435320100, 435325000
Abstract:
The identification of a novel gene, termed IκBNS, regulated during negative selection of immature CD4CD8double positive (DP) thymocytes in mice, and the human homolog of the gene, are described, along with the gene products produced by these genes. Methods of using the disclosed genes and gene products are also described.
Methods Of Identifying Agents Which Enhance Caspase Activity
US Patent:
7247438, Jul 24, 2007
Filed:
Oct 9, 1997
Appl. No.:
08/948124
Inventors:
Ellis Reinherz - Lincoln MA, US
Linda Clayton - Jamaica Plain MA, US
Timothy D. Ocain - Framingham MA, US
Raymond J. Patch - Framingham MA, US
Linda Clayton - Jamaica Plain MA, US
Timothy D. Ocain - Framingham MA, US
Raymond J. Patch - Framingham MA, US
Assignee:
Dana-Farber Cancer Institute - Boston MA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
Methods for identifying agents which enhance the activity of a caspase according to the invention are described, as well as methods for enhancing caspase activity and methods for enhancing apoptosis in a lymphocyte.